About: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 August 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2007 (uk) article scientifique publié en 2007 (fr) im August 2007 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 29 August 2007 (en) artículu científicu espublizáu n'agostu de 2007 (ast)
publication date	wds:Q59264385-9AF11D5C-2CD4-40E6-8DDA-44D2A07E6D6E
publication date	2007-08-29 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59264385-8730FAC7-8BFD-49FB-967C-524CC288FD20
language of work or name	English
cites work	wds:Q59264385-0407C849-697A-400F-ACB8-9EFE080DA5DE wds:Q59264385-0B9188A2-8309-485B-B4D0-B0BD566933F5 wds:Q59264385-1E609E5D-2F57-41DA-B43B-9810C8B1ABCD wds:Q59264385-24500C74-2195-49E5-BE17-E4A9CBC28AFD wds:Q59264385-2A7CE26D-AC10-4270-B99F-7E062BC4FE72 wds:Q59264385-3167E70F-1A8D-415A-9681-FF0A9AF78A2C wds:Q59264385-337089B2-CAE6-44C6-87B8-D3909D60F331 wds:Q59264385-3BEE2E5C-0F87-4376-A4D4-535E4AADC855 wds:Q59264385-3D16ABF8-AF01-427C-8EA1-16F7054710B0 wds:Q59264385-568ACCDB-5C64-4140-A4A2-6F0B7A78C05A wds:Q59264385-5CD7F194-9987-44C8-8CDC-1AA1DED2543F wds:Q59264385-6C987E7F-D8AC-4056-BF2C-06AECD4D3E6A wds:Q59264385-7EE945D0-AEF4-47E9-9E8B-A9458765BF48 wds:Q59264385-8295B8AA-1F7E-4B22-AD25-EC34140C826D wds:Q59264385-834DBDC9-A62B-4E5B-80E5-6AE36BAD56FB wds:Q59264385-8414EAFA-E2FF-4D24-8AF5-C8822622F377 wds:Q59264385-92092101-B3ED-43C2-B3FE-6D8C75ADB611 wds:Q59264385-92A63C88-6A17-4217-A255-CB42C165C81D wds:Q59264385-984146F6-612D-4774-8A30-538A13F5F682 wds:Q59264385-992B0B42-E6E7-4982-A99E-698489191C60 wds:Q59264385-9D5B6EA4-3083-4033-956F-C6FB00FB9086 wds:Q59264385-A2427F97-E5B4-46C7-AAA8-AFBAD748939B wds:Q59264385-AB7C2FCD-6A78-4F96-B25D-249544C58140 wds:Q59264385-AD222B8C-D4DD-47C5-BF45-4AFCE62BE8F4 wds:Q59264385-B1FF41F3-2C78-4981-BBE1-36886C2A2765 wds:Q59264385-C152D30C-9029-4DB7-B165-276E2688F80C wds:Q59264385-CC8CF962-E5DC-4FEE-A303-906DF125DC7F wds:Q59264385-E23FC94D-C7C4-4F82-A786-8EEFF696B548 wds:Q59264385-E507BA3C-A17C-4030-9EA3-CA9ADA6D36C3 wds:Q59264385-E63987FC-BF7F-40B2-B94E-CD16946A7C0D wds:Q59264385-E77101F7-DF89-49EE-BAC4-8D2AE55899EB wds:Q59264385-E9DE5005-9F08-4807-81D6-03580DE4D72E wds:Q59264385-EC493E51-E0C8-45B4-896E-CAB1E2F8356A wds:Q59264385-EEF25C1C-4D3F-41E8-BA6E-62988ADE2BAA wds:Q59264385-F19FFD2F-C976-4A1A-BBBC-82E06D4C366F wds:Q59264385-F2A0C81C-E6C2-446E-9797-83A01CB7F84F wds:Q59264385-F4805EC2-145E-438F-9CD9-3F362C102578 wds:Q59264385-FA52B106-56EA-48CC-882A-08DAFA70E967
cites work	The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Emerging biological roles for erythropoietin in the nervous system Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Secondary progressive multiple sclerosis: current knowledge and future challenges Multiple sclerosis A potential role for erythropoietin in focal permanent cerebral ischemia in mice. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo Erythropoietin: novel approaches to neuroprotection in human brain disease Erythropoietin treatment improves neurological functional recovery in EAE mice Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. In vivo evidence that erythropoietin protects neurons from ischemic damage Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models Development of a multiple sclerosis functional composite as a clinical trial outcome measure Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Effects of erythropoietin on brain function The role of erythropoietin in regulating angiogenesis A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production Managing erythropoietin hyporesponsiveness Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis
author name string	wds:Q59264385-0B786696-5B76-4407-A0E4-F9E3A08F4536 wds:Q59264385-1CCFCFB4-D540-46D8-873D-33B32CF2B6D1 wds:Q59264385-5F906338-1118-483A-9AFF-AD8CACEDBC9B wds:Q59264385-BE61659C-B49F-42C8-9B5F-47A57EA93947 wds:Q59264385-C4584E7C-5F27-4303-A6A9-348EE828C561 wds:Q59264385-F219080E-2BEA-44B1-BAC0-E1243BEFA667
author name string	Benjamin Fischer Michael Stiefel Claudia Bartels Christine Norra Nike Stender Felix Schellenberger
rdfs:label	Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software